These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28755527)

  • 1. Targeted dianthin is a powerful toxin to treat pancreatic carcinoma when applied in combination with the glycosylated triterpene SO1861.
    Bhargava C; Dürkop H; Zhao X; Weng A; Melzig MF; Fuchs H
    Mol Oncol; 2017 Nov; 11(11):1527-1543. PubMed ID: 28755527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial approach to increase efficacy of Cetuximab, Panitumumab and Trastuzumab by dianthin conjugation and co-application of SO1861.
    Gilabert-Oriol R; Weng A; Trautner A; Weise C; Schmid D; Bhargava C; Niesler N; Wookey PJ; Fuchs H; Thakur M
    Biochem Pharmacol; 2015 Oct; 97(3):247-55. PubMed ID: 26253687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861.
    Panjideh H; Niesler N; Weng A; Fuchs H
    Toxins (Basel); 2022 Jul; 14(7):. PubMed ID: 35878216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic Nanoparticle-Based Dianthin Targeting for Controlled Drug Release Using the Endosomal Escape Enhancer SO1861.
    Zarinwall A; Asadian-Birjand M; Seleci DA; Maurer V; Trautner A; Garnweitner G; Fuchs H
    Nanomaterials (Basel); 2021 Apr; 11(4):. PubMed ID: 33924180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dianthin-EGF is an effective tumor targeted toxin in combination with saponins in a xenograft model for colon carcinoma.
    von Mallinckrodt B; Thakur M; Weng A; Gilabert-Oriol R; Dürkop H; Brenner W; Lukas M; Beindorff N; Melzig MF; Fuchs H
    Future Oncol; 2014 Nov; 10(14):2161-75. PubMed ID: 25471031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dianthin-30 or gelonin versus monomethyl auristatin E, each configured with an anti-calcitonin receptor antibody, are differentially potent in vitro in high-grade glioma cell lines derived from glioblastoma.
    Gilabert-Oriol R; Furness SGB; Stringer BW; Weng A; Fuchs H; Day BW; Kourakis A; Boyd AW; Hare DL; Thakur M; Johns TG; Wookey PJ
    Cancer Immunol Immunother; 2017 Sep; 66(9):1217-1228. PubMed ID: 28501939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant toxin DAB389EGF is cytotoxic to human pancreatic cancer cells.
    Mishra G; Liu TF; Frankel AE
    Expert Opin Biol Ther; 2003 Oct; 3(7):1173-80. PubMed ID: 14519080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic antitumor effects of combined epidermal growth factor receptor and vascular endothelial growth factor receptor-2 targeted therapy.
    Tonra JR; Deevi DS; Corcoran E; Li H; Wang S; Carrick FE; Hicklin DJ
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2197-207. PubMed ID: 16609035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel epidermal growth factor receptor-signaling platform and its targeted translation in pancreatic cancer.
    Gilmour AM; Abdulkhalek S; Cheng TS; Alghamdi F; Jayanth P; O'Shea LK; Geen O; Arvizu LA; Szewczuk MR
    Cell Signal; 2013 Dec; 25(12):2587-603. PubMed ID: 23993964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dianthin and Its Potential in Targeted Tumor Therapies.
    Fuchs H
    Toxins (Basel); 2019 Oct; 11(10):. PubMed ID: 31614697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor blockade by antibody IMC-C225 inhibits growth of a human pancreatic carcinoma xenograft in nude mice.
    Overholser JP; Prewett MC; Hooper AT; Waksal HW; Hicklin DJ
    Cancer; 2000 Jul; 89(1):74-82. PubMed ID: 10897003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of tumor growth by targeted toxins in mice is dramatically improved by saponinum album in a synergistic way.
    Bachran C; Dürkop H; Sutherland M; Bachran D; Müller C; Weng A; Melzig MF; Fuchs H
    J Immunother; 2009 Sep; 32(7):713-25. PubMed ID: 19561537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small structural differences of targeted anti-tumor toxins result in strong variation of protein expression.
    Gilabert-Oriol R; Thakur M; Weise C; Dernedde J; von Mallinckrodt B; Fuchs H; Weng A
    Protein Expr Purif; 2013 Sep; 91(1):54-60. PubMed ID: 23867360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptotic activity and antitumor efficacy of PEGylated TNF-related apoptosis-inducing ligand (TRAIL) in a Mia Paca-2 cell-xenografted mouse model.
    Byeon HJ; Choi SH; Choi JS; Kim TH; Lee ES; Lee KC; Youn YS
    Biomed Pharmacother; 2014 Feb; 68(1):65-9. PubMed ID: 24268811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model.
    Hwang RF; Yokoi K; Bucana CD; Tsan R; Killion JJ; Evans DB; Fidler IJ
    Clin Cancer Res; 2003 Dec; 9(17):6534-44. PubMed ID: 14695158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor efficacy of capecitabine and celecoxib in irradiated and lead-shielded, contralateral human BxPC-3 pancreatic cancer xenografts: clinical implications of abscopal effects.
    Blanquicett C; Saif MW; Buchsbaum DJ; Eloubeidi M; Vickers SM; Chhieng DC; Carpenter MD; Sellers JC; Russo S; Diasio RB; Johnson MR
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8773-81. PubMed ID: 16361565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PANC-1 pancreatic cancer cell growth inhibited by cucurmosin alone and in combination with an epidermal growth factor receptor-targeted drug.
    Wang C; Yang A; Zhang B; Yin Q; Huang H; Chen M; Xie J
    Pancreas; 2014 Mar; 43(2):291-7. PubMed ID: 24518510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bispecific enediyne-energized fusion protein containing ligand-based and antibody-based oligopeptides against epidermal growth factor receptor and human epidermal growth factor receptor 2 shows potent antitumor activity.
    Guo XF; Zhu XF; Shang Y; Zhang SH; Zhen YS
    Clin Cancer Res; 2010 Apr; 16(7):2085-94. PubMed ID: 20332319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triphala inhibits both in vitro and in vivo xenograft growth of pancreatic tumor cells by inducing apoptosis.
    Shi Y; Sahu RP; Srivastava SK
    BMC Cancer; 2008 Oct; 8():294. PubMed ID: 18847491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of response to nab-paclitaxel by inhibition of insulin-like growth factor (IGF) signaling in preclinical pancreatic cancer models.
    Awasthi N; Scire E; Monahan S; Grojean M; Zhang E; Schwarz MA; Schwarz RE
    Oncotarget; 2016 Jul; 7(30):46988-47001. PubMed ID: 27127884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.